A successful management with electroconvulsive therapy of neuroleptic malignant syndrome due to amisulpride

被引:0
|
作者
Karayagmurlu, Ali [1 ]
Karayagmurlu, Elif [2 ]
Ustundag, Mehmet Fatih [3 ]
Yazla, Ece [4 ]
机构
[1] Gaziantep Child State Hosp, Dept Child & Adolescent Psychiat, Gaziantep, Turkey
[2] Gaziantep Univ, Dept Psychiat, Fac Med, Gaziantep, Turkey
[3] Erenkoy Training & Res Hosp Psychiat & Neurol Dis, Dept Psychiat, Istanbul, Turkey
[4] Hitit Univ, Fac Med, Dept Psychiat, Corum, Turkey
来源
ELECTRONIC JOURNAL OF GENERAL MEDICINE | 2018年 / 15卷 / 03期
关键词
amisulpride; atypical antipsychotics; neuroleptic malignant syndrome; electroconvulsive therapy;
D O I
10.29333/ejgm/83617
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Neuroleptic malignant syndrome is a severe complication that mainly occurs based on neuroleptic drug treatment and characterized with some autonomic symptoms, altered mental state, hyperthermia and muscle rigidity. Amisulpride is a unique atypical antipsychotic that selectively blocks D2 and D3 receptors presynaptically in the frontal cortex and atypical antipsychotics are rarely caused neuroleptic malignant syndrome (NMS). This study examine a 20-years old male with the diagnosis of acute psychotic disorder occurred amisulpride-induced NMS and successfully treated with Electroconvulsive Therapy (ECT). We decided to present that case because of the fact that there is only limited number of amisulpride-induced NMS cases reported in the literature.
引用
收藏
页数:4
相关论文
共 50 条
  • [31] ELECTROCONVULSIVE THERAPY AS AN EFFECTIVE TREATMENT IN NEUROLEPTIC MALIGNANT SYNDROME: PURPOSELY A CASE
    Ogando Portilla, N.
    Martinez Cortes, M.
    del Nido Varo, L.
    Torio Palmero, I.
    Ortega Bernardo, M. C.
    Jimenez-Arriero, M. A.
    EUROPEAN PSYCHIATRY, 2013, 28
  • [32] Neuroleptic malignant syndrome due to amisulpride in a patient with solvent-induced chronic toxic encephalopathy
    Peritogiannis, Vaios
    Tsouli, Sofia
    Pappas, Dimitrios
    Mavreas, Venetsanos
    Konitsiotis, Spiros
    CLINICAL NEUROPHARMACOLOGY, 2007, 30 (04) : 245 - 246
  • [33] Is amisulpride associated less with neuroleptic malignant syndrome? Review and hypothesis
    Vaios Peritogiannis
    Georgios Kalampokis
    Charalampos Lixouriotis
    Annals of General Psychiatry, 9 (Suppl 1)
  • [34] Successful Treatment of Both Refractory Neuroleptic Malignant Syndrome and Subsequent Catatonia With Electroconvulsive Therapy in a Patient With Suspected Kufs Disease
    Celik, Sacha
    de Gennaro, Veronica
    Silva, Joao C. - P. -
    Swierkosz-Lenart, Kevin
    von Gunten, Armin
    JOURNAL OF ECT, 2025, 41 (01) : 66 - 67
  • [35] Rapid symptom control in neuroleptic malignant syndrome with electroconvulsive therapy: A case report
    Katzell, Lauren
    Beydler, Emily
    dos Santos, Amilcar Silva
    Vijayvargiya, Richa
    Carr, Brent R.
    FRONTIERS IN PSYCHIATRY, 2023, 14
  • [36] Neuroleptic malignant syndrome associated with amisulpride and lithium: a case report
    Zaluska, Maria
    Brykalski, Jan
    Kszczotek, Maja
    Janota, Bertrand
    Dyduch, Agnieszka
    POSTEPY PSYCHIATRII I NEUROLOGII, 2014, 23 (04): : 202 - 205
  • [37] Electroconvulsive therapy for catatonia secondary to neuroleptic malignant syndrome in a patient with multiple sclerosis
    Harley, J. A.
    Peebles, C.
    Porter, R. J.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2019, 53 (07): : 703 - 704
  • [38] Electroconvulsive therapy in drug-induced psychiatric states and neuroleptic malignant syndrome
    Ozer, F
    Meral, H
    Aydin, B
    Hanoglu, L
    Aydemir, T
    Oral, T
    JOURNAL OF ECT, 2005, 21 (02) : 125 - 127
  • [39] INTENSIVE ELECTROCONVULSIVE THERAPY IN DRUG RESISTANT NEUROLEPTIC MALIGNANT SYNDROME - CASE REPORT
    Wysokinski, Adam
    PSYCHIATRIA DANUBINA, 2012, 24 (02) : 219 - 222